These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2563193)

  • 1. The clinical and screening age-at-onset distribution for the MEN-2 syndrome.
    Easton DF; Ponder MA; Cummings T; Gagel RF; Hansen HH; Reichlin S; Tashjian AH; Telenius-Berg M; Ponder BA
    Am J Hum Genet; 1989 Feb; 44(2):208-15. PubMed ID: 2563193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple endocrine neoplasia syndrome type 2: the value of screening and central registration. A study of 15 kindreds in The Netherlands.
    Vasen HF; Nieuwenhuijzen Kruseman AC; Berkel H; Beukers EK; Delprat CC; Van Doorn RG; Geerdink RA; Haak HR; Hackeng WH; Koppeschaar HP
    Am J Med; 1987 Nov; 83(5):847-52. PubMed ID: 2890300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diagnosis of the multiple endocrine neoplasia type 2 syndrome: consensus statement. European Community Concerted Action: Medullary Thyroid Carcinoma.
    Calmettes C; Ponder BA; Fischer JA; Raue F
    Eur J Clin Invest; 1992 Nov; 22(11):755-60. PubMed ID: 1362156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pheochromocytoma - chromaffin cell tumor].
    Szosland K; Kopff B; Lewiński A
    Endokrynol Pol; 2006; 57(1):54-62. PubMed ID: 16575763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?
    Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ
    Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma.
    Narod SA; Sobol H; Nakamura Y; Calmettes C; Baulieu JL; Bigorgne JC; Chabrier G; Couette J; de Gennes JL; Duprey J
    Hum Genet; 1989 Nov; 83(4):353-8. PubMed ID: 2572534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
    Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
    N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type IIb: a description of several patients and review of the literature.
    Montgomery TB; Mandelstam P; Tachman ML; Miller RE; Powell DE; Flueck JA; Kotchen TA
    J Clin Hypertens; 1987 Mar; 3(1):31-49. PubMed ID: 2883264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary endocrine tumour diseases].
    Husebye ES; Varhaug JE; Heimdal K
    Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2964-7. PubMed ID: 16276382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of screening for medullary thyroid carcinoma in families of patients with MEN 2.
    Frilling A; Goretzki PE; Bastian L; Roeher HD
    Henry Ford Hosp Med J; 1989; 37(3-4):122-3. PubMed ID: 2576942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytoma in multiple endocrine neoplasia type II: an example of the two-hit theory of neoplasia.
    Cerny JC; Jackson CE; Talpos GB; Yott JB; Lee MW
    Surgery; 1982 Nov; 92(5):849-52. PubMed ID: 6127813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
    Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
    N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endocrine polyadenomatosis of 2a type (MEN 2a). Clinical and genetic study of a family].
    Guillausseau PJ; Guillausseau C; Calmettes C; Feingold N; Demenais F; Sobol H; Gony J; Hors J; Schaison G; Seret D
    Ann Endocrinol (Paris); 1988; 49(1):17-21. PubMed ID: 2900619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics of multiple endocrine neoplasia].
    Conte-Devolx B; Niccoli P;
    Bull Acad Natl Med; 2010 Jan; 194(1):69-78; discussion 78-9. PubMed ID: 20669560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of multiple endocrine neoplasia type 2A--a clinical analysis.
    Shimotake T; Iwai N; Yanagihara J; Suzuki G; Takai S
    Jpn J Surg; 1990 May; 20(3):290-3. PubMed ID: 1972766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pheochromocytoma in multiple endocrine neoplasia.
    Raue F; Frank K; Meybier H; Ziegler R
    Cardiology; 1985; 72 Suppl 1():147-9. PubMed ID: 2865008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases.
    Vasen HF; van der Feltz M; Raue F; Kruseman AN; Koppeschaar HP; Pieters G; Seif FJ; Blum WF; Lips CJ
    Arch Intern Med; 1992 Jun; 152(6):1250-2. PubMed ID: 1350898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of hereditary medullary thyroid cancer with polymorphic DNA probes. Groupe d'Etude des Tumeurs a Calcitonine.
    Narod SA; Sobol H; Schuffenecker I; Ezekowitz RA; Lenoir GM
    Henry Ford Hosp Med J; 1989; 37(3-4):106-8. PubMed ID: 2576937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple endocrine neoplasia syndromes. Type 2].
    Juodele L; Juozaityte E; Zindzius A; Pundzius J
    Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary thyroid carcinoma, genes, and the prevention of cancer.
    Utiger RD
    N Engl J Med; 1994 Sep; 331(13):870-1. PubMed ID: 7915823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.